Topera Medical to Present at Bank of America Merrill Lynch Cardiovascular Device Innovation Day: a Look at Four Potentially Disruptive Innovations in Cardiovascular Devices

SAN DIEGO--(BUSINESS WIRE)--Topera Medical, a developer of innovative mapping systems that help identify the electrical source of cardiac arrhythmias, has been selected for a presentation and panel discussion on December 1, 2011 at the Bank of America Merrill Lynch Cardiovascular Device Innovation Day: A Look at Four Potentially Disruptive Innovations in Cardiovascular Devices. The event will be held at the Bank of America Merrill Lynch Offices at One Bryant Park in New York and will feature innovative cardiovascular technologies that have the potential to have a major impact on cardiovascular medicine over the next two to five years. Meeting presenters will provide a detailed overview of the science behind the featured technologies and address the potential market opportunity and impact of the technologies on today’s standard of care. Ruchir Sehra, MD, Executive Vice President of Regulatory, Quality and Scientific Affairs and Edward Kerslake, PhD, Chief Executive Officer at Topera, will present and participate in a panel discussion regarding the Company.

Back to news